In this issue:<br> &#183 Icon Finally Makes a Move by Acquiring Two Niche CROs<br> &#183 Feds Halt Trial Enrollment at University of Alabama and UPenn<br> &#183 Quarterly Reports <br> &#183 PPD Signs Internet, Genomics, Phase III Pacts <br> &#183 InSync in Pact with MSO<br> &#183 The CenterWatch Index<br> &#183 Personnel<br> &#183 Industry Briefs<br> &#183 Drug Pipeline News<br> &#183 Trial Results<br>